These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11089230)

  • 1. Quinolone interactions with DNA and DNA gyrase.
    Shen LL
    Methods Mol Biol; 2001; 95():171-84. PubMed ID: 11089230
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmid DNA supercoiling by DNA gyrase.
    Sayer PJ; Goble ML; Oram M; Fisher LM
    Methods Mol Biol; 2001; 95():25-33. PubMed ID: 11089216
    [No Abstract]   [Full Text] [Related]  

  • 3. Bactericidal assays for fluoroquinolones.
    Gootz TD
    Methods Mol Biol; 2001; 95():185-94. PubMed ID: 11089231
    [No Abstract]   [Full Text] [Related]  

  • 4. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase.
    Hilliard JJ; Krause HM; Bernstein JI; Fernandez JA; Nguyen V; Ohemeng KA; Barrett JF
    Adv Exp Med Biol; 1995; 390():59-69. PubMed ID: 8718602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.
    Zechiedrich EL; Khodursky AB; Cozzarelli NR
    Genes Dev; 1997 Oct; 11(19):2580-92. PubMed ID: 9334322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli.
    Zechiedrich EL; Khodursky AB; Bachellier S; Schneider R; Chen D; Lilley DM; Cozzarelli NR
    J Biol Chem; 2000 Mar; 275(11):8103-13. PubMed ID: 10713132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase II-catalyzed relaxation and catenation of plasmid DNA.
    Fortune JM; Osheroff N
    Methods Mol Biol; 2001; 95():275-81. PubMed ID: 11089239
    [No Abstract]   [Full Text] [Related]  

  • 9. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex.
    Willmott CJ; Maxwell A
    Antimicrob Agents Chemother; 1993 Jan; 37(1):126-7. PubMed ID: 8381633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of differential activities of ofloxacin enantiomers.
    Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin-induced DNA cleavage occurs at the dif resolvase locus in Escherichia coli and is the result of interaction with topoisomerase IV.
    Hojgaard A; Szerlong H; Tabor C; Kuempel P
    Mol Microbiol; 1999 Sep; 33(5):1027-36. PubMed ID: 10476036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of inhibition of topoisomerase IV by quinolone antibacterials.
    Khodursky AB; Cozzarelli NR
    J Biol Chem; 1998 Oct; 273(42):27668-77. PubMed ID: 9765303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase II-mediated cleavage of plasmid DNA.
    Burden DA; Froelich-Ammon SJ; Osheroff N
    Methods Mol Biol; 2001; 95():283-9. PubMed ID: 11089240
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective inhibition of DNA gyrase in vitro by a GC specific eight-ring hairpin polyamide at nanomolar concentration.
    Simon H; Kittler L; Baird E; Dervan P; Zimmer C
    FEBS Lett; 2000 Apr; 471(2-3):173-6. PubMed ID: 10767417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High pressure modulation of Escherichia coli DNA gyrase activity.
    Chilukuri LN; Fortes PA; Bartlett DH
    Biochem Biophys Res Commun; 1997 Oct; 239(2):552-6. PubMed ID: 9344868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
    Hammonds TR; Foster SR; Maxwell A
    J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
    Nakada N; Gmünder H; Hirata T; Arisawa M
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA gyrase and DNA supercoiling.
    Gellert M; Mizuuchi K; O'Dea MH; Ohmori H; Tomizawa J
    Cold Spring Harb Symp Quant Biol; 1979; 43 Pt 1():35-40. PubMed ID: 225107
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of DNA topoisomerases involved in immediate and transient DNA relaxation induced by heat shock in Escherichia coli.
    Ogata Y; Mizushima T; Kataoka K; Miki T; Sekimizu K
    Mol Gen Genet; 1994 Sep; 244(5):451-5. PubMed ID: 8078472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.